Labetalol Hydrochloride 25021-0317
Product NDC
25021-0317- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA214533
Need to source Labetalol Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Labetalol Hydrochloride | 5 mg/mL |
Drug Class
Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]
Packaging Options(2)
1 VIAL in 1 CARTON (25021-317-20) / 20 mL in 1 VIAL
1 VIAL in 1 CARTON (25021-317-40) / 40 mL in 1 VIAL